Forensic Analysis · Nondurable-Goods Wholesale · as of Nov 10, 2026

Nu Skin Enterprises, Inc. (NUS)

A forensic read on Nu Skin Enterprises, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective

Forensic grade

Safe

Financial health

7.4

Distress distance

Clean

Earnings quality

Forensic signals

22.0%

ROE

-14.3%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Nu Skin Enterprises, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 7.4, placing it in the Safe zone. 1 forensic signal was flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

5.5%

FY2025

Return on invested capital. Return on invested capital is 5.5% in the latest fiscal year, against 2.5% in FY2023, having run between -10.6% and 5.5% across FY2023–FY2025 with no direction held. After-tax operating profit was $31M in FY2023 and $54M in FY2025, with operating income at 2.5% of revenue in FY2023, -8.8% in FY2024 and 4.4% in FY2025. The capital base behind it came down -22% across FY2023–FY2025, from $1.2B to $969M, so this return is struck on a smaller base than it started on. FY2024's operating profit carried a $181M asset write-down that alone took about 12.6 points off that year's return; FY2024 sits between the two ends of FY2023–FY2025, so the charge shapes the path between them without moving the change across it. A non-cash write-down lowers the reported return in the year it lands.

Key fundamentals

Latest Revenue$1.49B

Revenue Growth YoY-14.3%

Revenue CAGR (2yr)-13.2%

Net Margin10.8%

Free Cash Flow$46.0M

Return on Equity22.0%

Debt / Equity0.28x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Nu Skin Enterprises, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 10, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.